Evidence map›Paper›PMID 35146176›Full record

ArticlePorto biomedical journal

AlergiaPT: A Portuguese media campaign to inspire people with allergies to make a positive change in their life.

André Moreira, Francisca de Castro Mendes, Tiago Rama, Diogo Mota, Diana Silva, Inês Pádua, Cristina Abreu, Maria João Vasconcelos, Mariana Farraia, Inês Paciência and 6 more

Abstract read
In one paragraph

Article in Porto biomedical journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

André MoreiraEPIUnit, Institute of Public Health, University of Porto, Portugal & Laboratory for Integrative and Translational Research in Population Health (ITR), Porto, Portugal.
Francisca de Castro MendesEPIUnit, Institute of Public Health, University of Porto, Portugal & Laboratory for Integrative and Translational Research in Population Health (ITR), Porto, Portugal.
Tiago RamaEPIUnit, Institute of Public Health, University of Porto, Portugal & Laboratory for Integrative and Translational Research in Population Health (ITR), Porto, Portugal.
Diogo MotaServiço de Imunoalergologia, Centro Hospitalar Universitário São João, Porto, Portugal.
Diana SilvaEPIUnit, Institute of Public Health, University of Porto, Portugal & Laboratory for Integrative and Translational Research in Population Health (ITR), Porto, Portugal.
Inês PáduaEPIUnit, Institute of Public Health, University of Porto, Portugal & Laboratory for Integrative and Translational Research in Population Health (ITR), Porto, Portugal.
Cristina AbreuEPIUnit, Institute of Public Health, University of Porto, Portugal & Laboratory for Integrative and Translational Research in Population Health (ITR), Porto, Portugal.
Maria João VasconcelosServiço de Imunoalergologia, Centro Hospitalar Universitário São João, Porto, Portugal.
Mariana FarraiaEPIUnit, Institute of Public Health, University of Porto, Portugal & Laboratory for Integrative and Translational Research in Population Health (ITR), Porto, Portugal.
Inês PaciênciaEPIUnit, Institute of Public Health, University of Porto, Portugal & Laboratory for Integrative and Translational Research in Population Health (ITR), Porto, Portugal.
João RufoEPIUnit, Institute of Public Health, University of Porto, Portugal & Laboratory for Integrative and Translational Research in Population Health (ITR), Porto, Portugal.
Renata BarrosEPIUnit, Institute of Public Health, University of Porto, Portugal & Laboratory for Integrative and Translational Research in Population Health (ITR), Porto, Portugal.
Patrícia PadrãoEPIUnit, Institute of Public Health, University of Porto, Portugal & Laboratory for Integrative and Translational Research in Population Health (ITR), Porto, Portugal.
Pedro MoreiraEPIUnit, Institute of Public Health, University of Porto, Portugal & Laboratory for Integrative and Translational Research in Population Health (ITR), Porto, Portugal.
Diana SeabraEPIUnit, Institute of Public Health, University of Porto, Portugal & Laboratory for Integrative and Translational Research in Population Health (ITR), Porto, Portugal.
Henrique BarrosEPIUnit, Institute of Public Health, University of Porto, Portugal & Laboratory for Integrative and Translational Research in Population Health (ITR), Porto, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Allergic diseases comprise a significant cause of morbidity worldwide and a substantial burden on the health and medical systems of both developed and emerging economies. Although highly prevalent, relatively severe, and largely impactful on the quality of life of patients, allergic diseases are commonly trivialized. Increasing awareness of the relevance of allergic diseases as a major public health problem might lead to an improved acknowledgment by governments and health authorities. Based on the positive impact that media campaigns might have on health-related behaviors, as well as the large use of social media by different types of users, social media might be used as a powerful tool for spreading awareness and education even more effective than traditional face-to-face communication. Therefore, we aimed to develop a social media-based communication program, the AlergiaPT, reaching all stakeholders, to increase the awareness of allergic diseases tackling the causes, prevention, control, and economic impact. The AlergiaPT will provide user-generated and interactive content toward engagement, include both long-form and short-form video productions toward education, as well as stories and time-sensitive content toward empowerment. It will be targeted to all populations, engaging different stakeholders. Contents will address the 5 campaign goals: i) allergy health is promoted; ii) tolerance is actively reinforced, and avoidance reduced; iii) treatment control and guided self-management of patients of asthma, rhinitis, food allergy, and atopic eczema are strengthened; iv) recognition and treatment of severe allergy and anaphylaxis are improved, and v) indoor air quality is promoted. Engagement on the campaign will be promoted through stepwise educational takeaways meetings using different social media, and targeting all audience groups, by promoting the organization of resources for common goals and the involvement of social media to improve public awareness. The impact of AlergiaPT will be assessed through google analytics.

Indexed as

allergyanaphylaxisasthmapublic health

Identifiers

PMID35146176
PMCPMC8824408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.